期刊文献+

108例特发性肺动脉高压预后的研究 被引量:2

The prognosis study of 108 idiopathic pulmonary arterial hypertension patients
原文传递
导出
摘要 目的分析特发性肺动脉高压(IPAH)的发病特点并评价超声心动图和右心导管检查指标在判断IPAH预后中的作用。方法回顾性分析2003年1月到2007年6月在阜外心血管病医院住院并诊断为IPAH的108例患者,对这些患者生存情况进行随访,数据分析采用SPSS13.0软件包。结果108例IPAH患者中女性和男性比为2.86:1,确诊的平均年龄为(32.5±12.6)岁,出现症状到确诊的平均时间为(34.9±36.3)个月,晕厥、肝脏肿大、咯血和下肢水肿的发生率分别为32.4%、27.8%、15.7%和14.8%。随访截止时间为2008年6月,平均随访(27.6±14.7)个月,随访到94例(87.0%),42例(38.9%)在随访期间死于右心衰竭,死亡病例平均存活时间为确诊后(11.6±9.4)个月,出院后1、2、3年的生存率分别为74%、58%、44%。单因素分析显示对生存有影响的指标有:肱动脉收缩压(P〈0.01,RR=0.937)、脉压(P〈0.01,RR=0.930)、右左心室舒张末径比(P=0.003,RR=3.222)、超声测得的肺动脉收缩压(P=0.002,RR=1.022)、右心导管检测的肺动脉收缩压(P=0.030,RR=1.026)、肺动脉平均压(P=0.031,RR=1.037)和全肺血管阻力(P=0.019,RR=1.001);多因素COX回归分析显示脉压(P〈0.01,RR=0.923)、超声测得的右左心室舒张末径比值(P=0.006,RR=3.126)和肺动脉收缩压(P=0.002,RR=1.022)、右心导管检测得的肺动脉收缩压(P=0.016,解=1.033)、肺动脉平均压(P=0.038,RR=1.038)和全肺血管阻力(P=0.017,RR=1.001)是IPAH患者预后的独立预测因子。结论IPAH多发生于中青年女性,症状缺乏特异性,不易确诊且预后极差,晕厥、肝脏肿大和下肢水肿提示患者病情较重,晕厥最常见,超声心动图是测量肺动脉压力较准确的方法,右心导管测得的全肺血管阻力、脉压和超声测定的肺动脉收缩压是IPAH患者预后的独立预测因子。 Objective To analyze the characteristics of idiopathic pulmonary arterial hypertension (IPAH)and predict the prognosis of IPAH by Echocardiogram and Right Heart Catheterization. Methods 108 IPAH patients who was diagnosed as IPAH in Fuwai hospital from Jan 2003 to Jun 2007 were retrospectively analyzed and followed up to June 2008, the statistical analysis software was SPSS 13. O. Result The mean age of the 108 IPAH patients was ( 32.5± 12.6) years , the ratio of female and male was 2.86: 1, the average time from appearing symptom to diagnosis was ( 34.9 ±36.3) months, the incidence of syncope, hepatomegaly, hemoptysis and Edema of lower extremity was 32.4% ,27.8% , 15.7% and 14.8% respectively. A total of 94 patients ( 87.0% ) were followed up for (27.6 ± 14.7 ) months, forty-two patients (38.9%) died of right heart failure, the mean death time was (11.6 ± 9.4) months after diagnosis, the survival rate of 1, 2 and 3 years was 74%, 58% and 44% respectively. These following variables could predict survival in univariate analysis : Systolic Blood Pressure (SBP) ( P 〈 0. 01, RR = 0. 937), pulse Pressure (PP) ( P 〈 0.01,RR = 0.930 ), left ventricular End-Diastolic Dimension (LVEDD) ( P = 0.004, RR = 0.924), right ventricular End-Diastolic Dimension (RVEDD) ( P = 0. 029, RR = 1. 045 ), RVEDD/LVEDD(P = 0. 003, RR = 3. 222 ), Pulmonary Arterial Systolic Pressure ( PASP ) measured by echocardiogram ( P = 0. 002, RR = 1. 022 ), PASP ( P = 0. 030, RR = 1. 026 ), mean Pulmonary Arterial Pressure (mPAP)( P = 0. 031, RR = 1. 037 ) and Pulmonary Vascular Resistance (PVR) measured by right heart catheter(P =0. 019,RR = 1. 001 ). in multivariate analysis, PP(P 〈0.01 ,RR =0. 923), RVEDD/LVEDD( P = 0. 006, RR = 3. 126) and PASP measured by Echocardiogram ( P = 0. 002, RR = 1. 022), PASP, mPAP, PVR measured by right heart catheter( P = 0.017 ,RR = 1. 001 ) were predictive. Conclusion IPAH was prone to attack young women with a poor prognosis, the diagnosis of IPAH at an early stage was difficult because of nonspecific symptom, syncope, hepatomegaly and Edema of lower extremity can predict the severity of IPAH, PVR measured by right heart catheterization, PP and PASP were independently predictive factors for IPAH.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2009年第8期708-711,共4页 Chinese Journal of Cardiology
关键词 高血压 肺性 心脏导管插入术 超声心动描记术 多普勒 彩色 预后 Hypertension,pulmonary Heart catheterization Echocardiography, Doppler, color Prognosis
  • 相关文献

参考文献15

  • 1Appelbaum L, Yigla M, Bendayan D, et al. Primary pulmonary hypertension in Israel : a national survey. Chest, 2001,119 : 1801 - 1806.
  • 2D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med, 1991,115:343-349.
  • 3Tueller C, Stricker H, Soccal P, et al. Swiss Society for Pulmonary Hypertension. Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss Med Wkly, 2008,138:379-384.
  • 4程显声,郭英华,何建国,荆志成.1996—2005年阜外心血管病医院肺动脉高压住院构成比变化[J].中华心血管病杂志,2007,35(3):251-254. 被引量:34
  • 5Kawut SM, Horn EM, Berekashvili KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol,2005, 95 : 199-203.
  • 6程显声.特发性肺动脉高压的诊断[J].中国循环杂志,2006,21(6):478-480. 被引量:8
  • 7袁永生,王锡田.特发性肺动脉高压39例临床分析[J].山东医药,2008,48(8):93-94. 被引量:2
  • 8Hatle L, Angelsen BA, Tromsdal A. Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound. Br Heart J,1981,45:157-165.
  • 9Kitabatake A, Inoue M, Asao M, et al. Noninvasive evaluation of the ratio of pulmonary to systemic flow in atrial septal defect by duplex Doppler echocardiography. Circulation, 1984,69:73-79.
  • 10Sandoval J, Bauerle O, Palomar A, et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation, 1994,89:1733-1744.

二级参考文献12

  • 1邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.肺动脉血栓栓塞症患者住院构成比与病死率的变迁[J].中华医学杂志,2005,85(23):1605-1607. 被引量:6
  • 2程显声.特发性肺动脉高压的诊断[J].中国循环杂志,2006,21(6):478-480. 被引量:8
  • 3荆志成.我国肺动脉高压专家共识阐释[J].中国实用内科杂志,2007,27(4):246-249. 被引量:53
  • 4Simonneau G, Gaffe N, Rubin I.J, et al. Clinical classification of pulmonary hypertension. J Am Coil Cardiol,2004, 43:5S-12S.
  • 5荆志成,主译.肺动脉高压康复指南(第3版).北京:人民军医出版社,2006:38-39.
  • 6Sciomer S, Badagliacca R, Fedele F. Pulmonary hypertension:echocardiographic assessment. Ital Heart J, 2005,6 (10):840-845.
  • 7Delgado JF, Conde E, Sanchez V. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail, 2005, 7(6) : 1011-1016.
  • 8Higham MA, Dawson D, Joshl J, et al. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J,2001, 17(3) : 350-355.
  • 9Simonneau G, Galie N, Robin LJ, et al. Clinical classification of pulmonary hypertension [J]. J Am Coll Candiol, 2004, 43(12) : 5-12.
  • 10Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines [ J ]. Chest,2004,126 ( 1 Suppl) :7-10.

共引文献41

同被引文献20

  • 1荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量:98
  • 2王献民,赵珊珊,刘斌,魏丽,周同甫.高原肺动脉高压190例[J].实用儿科临床杂志,2006,21(13):835-836. 被引量:3
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35:979-987.
  • 4Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonaryhypertension: a national prospective study. Ann Intern Med, 1987, 107:216-223.
  • 5D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med, 1991,115:343-349.
  • 6Zhang R, Dai LZ, Xie WP, et al. Survival of Chinese patients with pulmonary arterial hypertension in the modern management era. Chest, 2011, 140:276-278.
  • 7Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society ( ERS), endorsed by the International Society of Heart and Lung Transplantation(ISHLT). Eur Heart J, 2009, 30,2493-2537.
  • 8Humbert M, Sitbon O, Chaouat A, et ah pulmonary arterial hypertension in France results from a national registry. Am J Respir Crit Care Med, 2006,173 : 1023-1030.
  • 9Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest, 2010, 137:376-387.
  • 10Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest, 2007,132:373-379.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部